kneat.com (TSE:KSI) Upgraded at Cibc World Mkts

kneat.com (TSE:KSI) was upgraded by equities researchers at Cibc World Mkts to a “strong-buy” rating in a report released on Tuesday, Zacks.com reports.

Several other equities analysts have also weighed in on the stock. Ventum Cap Mkts raised shares of kneat.com to a “strong-buy” rating in a research report on Wednesday, August 7th. CIBC set a C$6.00 price target on shares of kneat.com and gave the company an “outperform” rating in a report on Tuesday.

kneat.com Trading Up 0.6 %

kneat.com stock opened at C$4.80 on Tuesday. kneat.com has a 12 month low of C$2.68 and a 12 month high of C$5.17. The company has a quick ratio of 1.50, a current ratio of 1.47 and a debt-to-equity ratio of 95.14. The stock has a market cap of C$412.80 million, a P/E ratio of -30.00, a P/E/G ratio of 597.67 and a beta of 1.08. The company’s fifty day simple moving average is C$4.76 and its 200-day simple moving average is C$4.44.

kneat.com (TSE:KSI) last posted its quarterly earnings results on Tuesday, August 6th. The company reported C($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of C($0.04). The company had revenue of C$11.68 million during the quarter, compared to the consensus estimate of C$11.45 million. kneat.com had a negative return on equity of 51.13% and a negative net margin of 31.19%. As a group, sell-side analysts forecast that kneat.com will post -0.12 EPS for the current fiscal year.

kneat.com Company Profile

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.